{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T11:13:03Z","timestamp":1784718783122,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007166","name":"Jiangsu Provincial Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.03.060","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T07:34:42Z","timestamp":1586504082000},"page":"3952-3959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparative evaluation of ELPylated virus-like particle vaccine with two commercial PCV2 vaccines by experimental challenge"],"prefix":"10.1016","volume":"38","author":[{"given":"Yangyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaichang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.060_b0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/295064a0","article-title":"A very small porcine virus with circular single-stranded DNA","volume":"295","author":"Tischer","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.03.060_b0010","first-page":"6","article-title":"Circovirus vaccination in pigs with subclinical porcine circovirus type 2 infection complicated by ileitis","volume":"19","author":"Young","year":"2011","journal-title":"J Swine Health Prod"},{"key":"10.1016\/j.vaccine.2020.03.060_b0015","first-page":"2","article-title":"PCV2: ticking time bomb","volume":"18","author":"Allan","year":"2002","journal-title":"Pig Prog"},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.060_b0020","first-page":"259","article-title":"The emergence of a new strain of porcine circovirus-2 in Ontario and Quebec swine and its association with severe porcine circovirus associated disease\u20142004\u20132006","volume":"72","author":"Carman","year":"2008","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.vaccine.2020.03.060_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","article-title":"Porcine circovirus type 2 (PCV2) infections: Clinical signs, pathology and laboratory diagnosis","volume":"164","author":"Segal\u00e9s","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2020.03.060_b0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tvjl.2010.06.015","article-title":"Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs","volume":"189","author":"Lyoo","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2020.03.060_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tvjl.2014.02.002","article-title":"Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines","volume":"200","author":"Seo","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2020.03.060_b0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.virol.2007.08.014","article-title":"Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line","volume":"369","author":"Zhu","year":"2007","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2020.03.060_b0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jviromet.2012.11.001","article-title":"Comparative analysis of different methods to enhance porcine circovirus 2 replication","volume":"187","author":"Yang","year":"2013","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2020.03.060_b0050","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2007.12.019","article-title":"Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins","volume":"26","author":"Fort","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.060_b0055","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/bip.360241212","article-title":"Phase-structure transitions of the elastin polypentapeptide-water system within the framework of composition temperature studies","volume":"24","author":"Urry","year":"1985","journal-title":"Biopolymers"},{"key":"10.1016\/j.vaccine.2020.03.060_b0060","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/15100","article-title":"Purification of recombinant proteins by fusion with thermally-responsive polypeptides","volume":"17","author":"Meyer","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2020.03.060_b0065","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.addr.2010.05.004","article-title":"Drug delivery to solid tumors by elastinlike polypeptides","volume":"62","author":"McDaniel","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2020.03.060_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jnc.12782","article-title":"The design and delivery of PKA inhibitory polypeptide to treat SCA1","volume":"131","author":"Hearst","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.vaccine.2020.03.060_b0075","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.cbpa.2006.10.010","article-title":"Stimulus responsive elastin biopolymers: Applications in medicine and biotechnology","volume":"10","author":"Chilkoti","year":"2006","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.vaccine.2020.03.060_b0080","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/ja0764862","article-title":"Temperature triggered self-assembly of polypeptides into multivalent spherical micelles","volume":"130","author":"Dreher","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2020.03.060_b0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/1061186X.2015.1077847","article-title":"Immune-tolerant elastin-like polypeptides (iTEPs) and their application as CTL vaccine carriers","volume":"24","author":"Cho","year":"2016","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2020.03.060_b0090","article-title":"Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2","author":"Li","year":"2019","journal-title":"Viral J"},{"key":"10.1016\/j.vaccine.2020.03.060_b0095","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.vaccine.2008.12.043","article-title":"A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design","volume":"27","author":"Chen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.060_b0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vetmic.2009.09.072","article-title":"Emergence of a new type of porcine circovirus in swine (PCV): a type 1 and type 2 PCV recombinant","volume":"144","author":"Gagnon","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.060_b0105","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.1016\/j.vaccine.2012.08.065","article-title":"Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions","volume":"30","author":"Seo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.060_b0110","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.vaccine.2011.02.034","article-title":"Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2","volume":"29","author":"Kim","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.060_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.vetmic.2010.10.020","article-title":"Shedding and infection dynamics of porcine circovirus type 2 (PCV2) after experimental infection","volume":"149","author":"Patterson","year":"2011","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.060_b0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application","volume":"194","author":"Chae","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2020.03.060_b0125","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/pro.2063","article-title":"Biodegradation of elastin-like polypeptide nanoparticles","volume":"21","author":"Shah","year":"2012","journal-title":"Protein Sci"},{"key":"10.1016\/j.vaccine.2020.03.060_b0130","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/acs.biomac.7b00064","article-title":"Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine","volume":"18","author":"Pille","year":"2017","journal-title":"Biomacromolecules"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:08Z","timestamp":1759401788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20304606"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative evaluation of ELPylated virus-like particle vaccine with two commercial PCV2 vaccines by experimental challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}